| 1 |
27633099 | Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway. | 2016 Nov |
1 |
| 2 |
26124325 | MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In Vitro. | 2015 Jul |
2 |
| 3 |
22086611 | Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G(2)/M arrest and apoptosis. | 2013 Feb |
1 |
| 4 |
21989330 | The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer. | 2012 Jun |
2 |
| 5 |
22709873 | Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines. | 2012 Jun 18 |
2 |
| 6 |
20571878 | Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells. | 2011 Dec |
1 |
| 7 |
19141783 | Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice. | 2009 Jan 21 |
2 |
| 8 |
17513611 | Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles. | 2007 May |
1 |